MyMD Pharmaceuticals Rebrands to TNF Pharmaceuticals; Trading Under New Symbol to Begin Wednesday
MyMD Pharmaceuticals (MYMD) said Monday it has rebranded to TNF Pharmaceuticals to reflect its focus on targeting TNF-alpha for immune and metabolic system regulation.TNF's stock will begin trading
Express News | Tnf Pharmaceuticals: Common Stock, Listed on Nasdaq to Begin Trading Under New Stock Symbol "Tnfa," Effective Before Market Open on Wednesday, July 24
Express News | MyMD Pharmaceuticals Announces Corporate Rebranding to New Name Tnf Pharmaceuticals, Inc.
Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More
As Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 for its 19th edition, gathering top CEOs, investors and investors and leaders in the cannabis industry, let's scroll through th
MyMD Pharmaceuticals Files to Sell 473,841 Shares of Common Stock for Holders
Express News | MyMD Pharmaceuticals Announces Dr. Mitchell Glass As President And CMO
MyMD Pharmaceuticals Appoints New Independent Board Member Stephen Friscia >MYMD
MyMD Pharmaceuticals Appoints New Independent Board Member Stephen Friscia >MYMD
Express News | MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.d. as President and Chief Medical Officer
MyMD Pharmaceuticals (MYMD) Stock Sees Surprising After-Hours Surge
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) experienced a relatively quiet trading session on Thursday, with its stock price barely moving throughout the day. However, the after-hours market told a different story as MYMD embarked on an unexpected upward rally, surging nearly 25% to reach $2.47 per share. This remarkable movement was accompanied by a significant trading ...
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersMyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 46.0% to $2.89 during Thursday's after-market session. The market value of their outstanding shares is at $6.6 million. Adaptimmune Therapeutics (N
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersRezolute (NASDAQ:RZLT) stock increased by 52.7% to $4.58 during Tuesday's after-market session. The company's market cap stands at $183.8 million. The company's, Q3 earnings came out 4 days ago
Tandem Diabetes Care, Guardion Health, GT Biopharma Among Healthcare Movers
PharmaCyte Biotech Makes $7M Investment In MyMD Pharmaceuticals; Investment In Life Sciences Solidifies Previously Announced Strategy To Utilize Significant Cash Position To Create Additional Stockholder Value
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) (
Express News | MyMD Pharmaceuticals-up to $42 Mln in Two-Part Funding From New Strategic Investor, Existing Shareholders With Committed Closing of $14 Mln up Front
Express News | MyMD Secures $14 Million From Investors
Express News | MyMD Pharmaceuticals Inc - Secured $7 Mln in Commitments in Two Private Placement Funding Rounds Led by Strategic Investor, PharmaCyte Biotech, Inc
Express News | MyMD Pharmaceuticals Secures Strategic Investments
MyMD Pharmaceuticals | 10-Q: Quarterly report
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free cas
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers